UltraPlex
UltraPlex pioneering sustainable and cost-efficient liposome-based RNA therapeutics delivery.
Status:
Pre-business
SDGs:
Good health and well-being
Industry:
Life science and medical
Impact:
Quality of life
Origin:
Research to Business
School:
School of Science
Established:
2025
The UltraPlex project develops a next-generation liposome-based drug delivery system for RNA therapeutics that is sustainable, cost-efficient, and scalable for pharmaceutical applications. Traditional liposomal formulations face challenges such as high production costs, solvent dependency, material waste, and therapeutic molecule encapsulation inefficiency issues, limiting their commercial viability. UltraPlex addresses these challenges by integrating green chemistry, nanotechnology, and focused ultrasound principles to create an eco-friendly and efficient drug delivery platform.
Contact
Christopher Fogarty
Business Developer
Read more about innovation services
News from innovation ecosystem
Finland’s green transition requires innovation and collaboration
The alumni seminar of the school of chemical engineering brought together experts in research, industry and innovation to consider how Finland can harness the opportunities of the green transition.
We are looking for teaching assistants for spring 2027 courses
Become a teaching assistant in the Department of Computer Science
Earn points through exercise – Join UniSport’s Mount Everest challenge
UniSport's HeiaHeia wellbeing app inspires everyday wellbeing actions.